# Marico share price today (Marico Ltd, NSE: MARICO)

> Marico share price today: ₹878.40 at the NSE close on 3 November 2026, up 22.0% in a year. Marico (NSE: MARICO) is worth ₹1,14,210 crore, trades at a P/E of 60.5 and has closed between ₹711.60 and ₹878.40 over the past 52 weeks. > Marico Ltd's results are improving, and its P/E is near the top of its own history, higher than 96% of past readings. MARICO · FMCG - Personal Care · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/marico-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Growing steadily, from fewer quarters than usual
- Price: ₹878.40 (+22.0% in a year)
- P/E: 60.5× (higher than 96% of the last 11 years)
- Revenue (Jun 2026): ₹3,957 Cr (+22.9% on a year ago)
- Profit (Jun 2026): ₹652 Cr (+27.1% on a year ago)
- Operating margin: 21.0% (+1.0 points on a year ago)
- ROCE: 47%, FY26
- Profit that came in as cash: 97%, last 3 years

The main question: results are strong, and the P/E is higher than 96% of its own history. ## What is the Marico share price today? Marico Ltd's share price was ₹878.40 at the close on 3 November 2026. It has been rising for 80 weeks. That is 10.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹712 and ₹878, and at that close it was at the high of that range. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 1 week in a row. Over the last 11 years the share price moved +270% while the NIFTY 500 moved +257%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Marico this quarter? Three changes stood out: revenue up on a year earlier for 10 quarters in a row, best operating margin in 8 quarters and highest quarterly profit in 15 quarters. 1. Revenue up on a year earlier for 10 quarters in a row In the June 2026 quarter revenue was ₹3,957 crore, +22.9% on a year earlier. Why: Revenue rose because the company sold more hair oil in India. Parachute Rigids had its best volume growth in 20 quarters. Next results: check India volume growth after the Parachute price cut. From the earnings call on 4 Aug 2026. 2. Best operating margin in 8 quarters Operating margin was 21% in the June 2026 quarter, against 20% a year earlier. Why: Higher spending on ads and some other raw materials ate into that gain. From the earnings call on 4 Aug 2026. 3. Highest quarterly profit in 15 quarters Profit of ₹652 crore in the June 2026 quarter is the highest of the last 15 quarters. Next results: check whether higher input costs eat into the profit gain. From the earnings call on 4 Aug 2026. ## What are Marico's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Marico reported revenue of ₹3,957 crore, up 22.9% from ₹3,221 crore a year earlier, and a profit of ₹652 crore, up 27.1% from ₹513 crore. ### Marico results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹3,957 crore | ₹3,221 crore | +22.9% |
| Profit | ₹652 crore | ₹513 crore | +27.1% |
| Earnings per share | ₹4.85 | ₹3.89 | +24.7% |
| Operating margin | 21.0% | 20.0% | +1.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Marico's management discussed these results on a call held on 4 August 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Marico share price history? Marico closed at ₹878.40 on 3 November 2026, up 22.0% from ₹719.95 a year earlier (31 October 2025) and up 57.5% over five years. Its highest weekly close since February 2016 was ₹878.40 on 3 November 2026. ### Marico share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹764.10 | +15.0% |
| 1 month ago · 1 Oct 2026 | ₹780.10 | +12.6% |
| 6 months ago · 30 Apr 2026 | ₹775.00 | +13.3% |
| 1 year ago · 31 Oct 2025 | ₹719.95 | +22.0% |
| 3 years ago · 3 Nov 2023 | ₹528.05 | +66.3% |
| 5 years ago · 4 Nov 2021 | ₹557.85 | +57.5% |
| 10 years ago · 4 Nov 2016 | ₹261.60 | +235.8% |
| Earliest weekly close in our records · 26 Feb 2016 | ₹237.55 | +269.8% |
| Highest weekly close since February 2016, also the 52-week high · 3 Nov 2026 | ₹878.40 | 0.0% |
| Lowest weekly close since February 2016 · 4 Mar 2016 | ₹237.25 | +270.2% |
| 52-week low (weekly close) · 7 Nov 2025 | ₹711.60 | +23.4% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (565 weekly closes from 26 February 2016 to 3 November 2026.)

## What is the latest news on Marico? 3 Nov 2026: Marico closed at ₹878.40, up 15.0% on the week and up 12.6% on the month. 4 Aug 2026: Marico held its results call for April to June 2026. Management guided: FY27 consolidated revenue above ₹15,000 crore with double-digit growth. ### Earlier

- 30 Jul 2026: ex-date for a dividend of ₹4 a share. - Results for April to June 2026: Revenue up 22.9% and profit up 27.1% on a year earlier. ## What dividend does Marico pay? Marico paid ₹4 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.46% at the ₹878.40 close on 3 November 2026. The last was a dividend of ₹4 a share, ex-date 30 July 2026. ### Marico dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 30 Jul 2026 | ₹4 | Dividend | same day |
| 1 Aug 2025 | ₹7 | Dividend | same day |
| 7 Feb 2025 | ₹3.50 | Interim | same day |
| 6 Mar 2024 | ₹6.50 | Interim | same day |
| 7 Nov 2023 | ₹3 | Interim | same day |
| 8 Mar 2023 | ₹4.50 | Interim | same day |
| 4 Feb 2022 | ₹6.25 | Interim | 7 Feb 2022 |
| 8 Nov 2021 | ₹3 | Interim | 9 Nov 2021 |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Marico Ltd paid out 30% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Marico management say on the latest results call? On the call for April to June 2026, held on 4 August 2026, Marico's management guided: FY27 consolidated revenue above ₹15,000 crore with double-digit growth. > “The only thing I want to mention is that 20% or higher growth is certainly not conservative by any standards. That is something we will definitely aspire to deliver.”
> Saugata Gupta, MD & CEO, on the call for April to June 2026

### What management guided

- FY27 operating profit growth high-teens base case, with an aspiration of 20%. - FY27 India volume high-single-digit; Parachute mid-single-digit and VAHO double-digit/high-teens; international mid-teens constant-currency; another double-digit India quarter planned within three quarters. - Copra expected range-bound around 30-35% below last year's peak; Q2 input costs relatively higher, with no further Parachute pricing action expected. - FY27 consolidated tax rate about 18%; FY28 around 19-20%. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/3891/Conference Call/CC-Aug26.pdf). (From the call for April to June 2026, 4 August 2026.)

## What to watch in Marico's next results? When Marico reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: India volume trajectory, especially Parachute normalization after the announced price intervention - check the next quarter's print. - What to check (from the call)
- India volume trajectory, especially Parachute normalization after the announced price intervention - check the next quarter's print. - Q2 gross-margin resilience against LLP, polymer and edible-oil inflation - check whether copra relief persists. - Digital-first profitability progression, especially Plix and smaller brands, against the stated profitability path. - International growth quality, separating Vietnam and MENA execution from Bangladesh macro softness in the next print. ## Which stock lists is Marico on? Marico is not on any of our India lists this week. ## Is Marico profitable? Marico Ltd earned ₹652 Cr of net profit in the Jun 2026 quarter, +27.1% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹1,813 Cr. Over 10 years profit has grown 9.6% a year on average. That is 16.5% of the quarter's revenue. The same quarter a year earlier earned ₹513 Cr. For the full year, FY26 profit was ₹1,813 Cr (+9.3% on the year before). Why profit moved: revenue changed +22.9% on a year earlier and the margin moved +1.0 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +14.6% and revenue +25.3%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Marico make, and is it growing? Marico Ltd reported ₹3,957 Cr of revenue in the Jun 2026 quarter, +22.9% on the same quarter a year earlier. That is the 10th quarter in a row with growth on the year before. Over 10 years it has grown 8.5% a year on average. The last full year, FY26, came in at ₹13,611 Cr. The last four reported quarters add to ₹14,277 Cr. FY26 revenue was ₹13,611 Cr, +25.7% on the year before. Recent pace: the last four quarters grew +25.3% on average, against 8.5% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +25.1%, against +20.6% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +15.0%, against +12.6% a year (stabilising). ## How much of every ₹100 of sales does Marico keep? Marico Ltd's operating margin was 21.0% in the Jun 2026 quarter, 1.0 percentage points higher than the same quarter a year ago. Across 13 years it has been between 15.0% and 21.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +0.4 percentage points on the year while gross margin changed +0.3 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Marico's profit turning into cash? Over the last 3 years, 97% of Marico Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹2,084 Cr of operating cash against ₹1,813 Cr of profit. After ₹1,122 Cr of spending on assets, ₹962 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 97% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle. What to look at next: the bigger use of cash is spending on new assets, at 3.6× depreciation over three years. The next section checks what that spending is building. ## Where does Marico's cash go? Marico Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 12 days in FY26, down from 17 days in FY21. It spent ₹1,943 Cr on assets over the last 3 years. Customers take 35 days to pay, and stock sits for 85 days on average. At FY26 sales of ₹13,611 Cr, each day of that cycle ties up about ₹37.3 Cr, so roughly ₹447 Cr is tied up in the business at any time. FY26: customers took 35 days to pay and stock sat for 85 days, about 2.8 months of sales sitting as stock, for a full cycle of 12 days, shorter than FY21's 17. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 85 days. Customers pay about 35 days after that. Suppliers are paid at 108 days. Together that makes the 12-day cycle. Spending on assets: ₹1,943 Cr over the last 3 years, against ₹538 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹85.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Marico's P/E ratio, and how does it compare with its own history? Marico Ltd's P/E is 60.5×, near the high end of its own history: higher than 96% of past readings. Its usual P/E (the middle reading) is 52.0×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +8.0% while the price moved +22.0%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved +9.5% a year; about +9.3% a year came from earnings growth and about +0.2 percentage points from the multiple (roughly no change); over 10 years the price moved +12.9% a year; about +9.0% a year came from earnings growth and about +3.9 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. The PEG ratio and its quarterly curve, which only the second data source has, are not shown on this page: its two data sources disagree by up to 4.0% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Is the Marico business getting better or worse? Marico Ltd's business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROCE is steady at 47.0%. This is based on 8 quarters of 4 measures, with some gaps. Why it matters: steady growth with healthy returns is how a business compounds over time. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does Marico earn on its capital? Marico Ltd earned a ROCE of 47% in FY26. That is up from a low of 29% in FY14. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 13.3% net margin and 1.37× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 13.3% net margin × 1.37× asset turnover × 2.36× leverage (assets divided by equity) ≈ 43.0% on equity. The margin does its share; borrowing is a big part of it. The quarterly return lines and the return-on-capital-used (ROIC) line, which only the second data source has, are not shown on this page: its two data sources disagree by up to 4.0% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Does Marico have too much debt? Marico Ltd had ₹557 Cr of borrowings against ₹4,210 Cr of equity in FY26, so its debt is 0.13× its equity. Its operating profit is 44 times its interest bill. Over 5 years borrowings went from ₹511 Cr to ₹557 Cr. Over the last 3 of those years it spent ₹1,943 Cr on assets. Part of the spending on assets is being paid for with borrowed money. The total-debt and debt-to-equity series, which only the second data source has, are not shown on this page: its two data sources disagree by up to 4.0% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## What is the Marico shareholding pattern? Domestic institutions raised their stake in Marico Ltd by 3.0 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 14.1% of the company. Foreign institutions moved −2.6 points over the same period, to 22.3%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: +3.0 points over 8 quarters, to 14.1%; Foreign institutions: −2.6 points over 8 quarters, to 22.3%; Promoters: −0.4 points over 8 quarters, to 58.8%. Why the owners changed: foreign institutions moved −2.6 points and domestic institutions +3.0 points over 8 quarters, while promoters stayed about the same. One group of institutions took over shares from the other; it is not a change of mind by the people running the company. ## How far is Marico from balance-sheet trouble? For Marico Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Marico rank in its industry? 66.5 out of 100, rank 3 of 12 in FMCG - Personal Care, with 78% of the evidence available. Marico Ltd scores 66.5 out of 100 against the 12 companies it is compared with in FMCG - Personal Care, ranking 3. Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. The four parts add up to the total exactly: 24.4 + 17.9 + 6.8 + 17.4 = 66.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Marico compared with? Marico ranks 3 of 12 FMCG - Personal Care companies on the 4-Factor Sector Score, with 66.5 out of 100. 1. [Bajaj Consumer Care Ltd](https://www.sectoralpha.in/stocks/bajaj-consumer-care-ltd) BAJAJCON · quiet · Most evidence points up · 100% evidence 70.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.7/35 · Revenue 28% · Profit 84.6% · Operating margin change 7 points · 100% evidence Capital efficiency 19.2/25 · ROCE 30% · Operating margin 25% · 100% evidence Valuation 11.7/20 · P/E 19.3× · PEG 1.64 · 100% evidence Relative strength 6.5/20 · Lead over its industry 0.2% · Lead over NIFTY 500 -10.2% · 1 year 33.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 32.7 + 19.2 + 11.7 + 6.5 = 70.1 · What this means: Earnings are strong; relative strength in its sector is 0.2% and the one-year return is 33.5%. 2. [Hindustan Unilever Ltd](https://www.sectoralpha.in/stocks/hindustan-unilever-ltd) HINDUNILVR · basing · Most evidence points up · 100% evidence 69.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 9.5% · Profit 38% · Operating margin change -2 points · 100% evidence Capital efficiency 15.8/25 · ROCE 28.4% · Operating margin 22% · 100% evidence Valuation 17.2/20 · P/E 39.1× · PEG 0.72 · 100% evidence Relative strength 12.8/20 · Lead over its industry 1% · Lead over NIFTY 500 -9.9% · 1 year -21% · 100% evidence · 0 of 12 weeks ahead Exact sum: 23.4 + 15.8 + 17.2 + 12.8 = 69.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. Marico Ltd this page MARICO · quiet · Most evidence points up · 78% evidence 66.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.4/35 · Revenue 25.1% · Profit 15% · Operating margin change 1 points · 83% evidence Capital efficiency 17.9/25 · ROCE 47% · Operating margin 21% · 76% evidence Valuation 6.8/20 · P/E 55.1× · PEG n/a · 50% evidence Relative strength 17.4/20 · Lead over its industry 18.9% · Lead over NIFTY 500 6.5% · 1 year 11.2% · 100% evidence · 1 of 12 weeks ahead Exact sum: 24.4 + 17.9 + 6.8 + 17.4 = 66.5 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Gillette India Ltd](https://www.sectoralpha.in/stocks/gillette-india-ltd) GILLETTE · turning · Evidence leans up · 81% evidence 64.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.0/35 · Revenue 8% · Profit 18.4% · Operating margin change -1 points · 88% evidence Capital efficiency 18.1/25 · ROCE 90.7% · Operating margin 29% · 100% evidence Valuation 13.6/20 · P/E 34.5× · PEG 1.7 · 100% evidence Relative strength 10.1/20 · Lead over its industry n/a · Lead over NIFTY 500 -5.5% · 1 year -21.5% · 25% evidence · 0 of 12 weeks ahead Exact sum: 23 + 18.1 + 13.6 + 10.1 = 64.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Procter & Gamble Hygiene and Health Care Ltd](https://www.sectoralpha.in/stocks/procter-gamble-hygiene-and-health-care-ltd) PGHH · basing · Evidence leans up · 81% evidence 52.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue -1.6% · Profit -4.7% · Operating margin change -9 points · 88% evidence Capital efficiency 17.6/25 · ROCE 157% · Operating margin 19% · 100% evidence Valuation 13.3/20 · P/E 28.1× · PEG 1.77 · 100% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -27.7% · 1 year -48.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 13.9 + 17.6 + 13.3 + 7.5 = 52.3 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 6. [Colgate-Palmolive (India) Ltd](https://www.sectoralpha.in/stocks/colgate-palmolive-indialtd) COLPAL · quiet · Evidence leans up · 85% evidence 51.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.5/35 · Revenue 8.7% · Profit 2.6% · Operating margin change -3 points · 100% evidence Capital efficiency 21.6/25 · ROCE 108% · Operating margin 28% · 100% evidence Valuation 8.4/20 · P/E 31.4× · PEG 6.07 · 100% evidence Relative strength 8.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -17.1% · 1 year -28.8% · 25% evidence · 0 of 12 weeks ahead Exact sum: 12.5 + 21.6 + 8.4 + 8.5 = 51 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Dabur India Ltd](https://www.sectoralpha.in/stocks/dabur-india-ltd) DABUR · basing · Evidence leans up · 81% evidence 51.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.2/35 · Revenue 7.4% · Profit 10.9% · Operating margin change 0 points · 88% evidence Capital efficiency 14.9/25 · ROCE 20.3% · Operating margin 20% · 100% evidence Valuation 9.1/20 · P/E 32.7× · PEG 5.04 · 100% evidence Relative strength 8.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -14.7% · 1 year -25% · 25% evidence · 0 of 12 weeks ahead Exact sum: 18.2 + 14.9 + 9.1 + 8.8 = 51 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Emami Ltd](https://www.sectoralpha.in/stocks/emami-ltd) EMAMILTD · basing · Evidence leans down · 96% evidence 43.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.0/35 · Revenue 2.8% · Profit -8.2% · Operating margin change -1 points · 88% evidence Capital efficiency 15.1/25 · ROCE 28.1% · Operating margin 22% · 100% evidence Valuation 8.9/20 · P/E 20.7× · PEG 2.99 · 100% evidence Relative strength 10.1/20 · Lead over its industry -3.2% · Lead over NIFTY 500 -13.6% · 1 year -32.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 9 + 15.1 + 8.9 + 10.1 = 43.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Zydus Wellness Ltd](https://www.sectoralpha.in/stocks/zydus-wellness-ltd) ZYDUSWELL · quiet · Evidence leans down · 96% evidence 39.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Revenue 66.3% · Profit -42.5% · Operating margin change -1 points · 88% evidence Capital efficiency 7.9/25 · ROCE 4.9% · Operating margin 17% · 100% evidence Valuation 6.0/20 · P/E 66.5× · PEG 1.75 · 100% evidence Relative strength 12.7/20 · Lead over its industry 12.9% · Lead over NIFTY 500 1.1% · 1 year -2.9% · 100% evidence · 2 of 12 weeks ahead Exact sum: 12.8 + 7.9 + 6 + 12.7 = 39.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Godrej Consumer Products Ltd](https://www.sectoralpha.in/stocks/godrej-consumer-products-ltd) GODREJCP · quiet · Evidence leans down · 100% evidence 35.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue 12.9% · Profit 8.6% · Operating margin change -1 points · 100% evidence Capital efficiency 10.3/25 · ROCE 18.8% · Operating margin 19% · 100% evidence Valuation 4.3/20 · P/E 39.4× · PEG 7.49 · 100% evidence Relative strength 2.9/20 · Lead over its industry -8.6% · Lead over NIFTY 500 -18.5% · 1 year -26.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 18.1 + 10.3 + 4.3 + 2.9 = 35.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Jyothy Labs Ltd](https://www.sectoralpha.in/stocks/jyothy-labs-ltd) JYOTHYLAB · quiet · Most evidence points down · 96% evidence 34.0 out of 100 Growth Capital Valuation Relative
12. [Polo Queen Industrial and Fintech Ltd](https://www.sectoralpha.in/stocks/polo-queen-industrial-and-fintech-ltd) PQIF · Too little evidence to rank firmly · 33% evidence 39.0 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [FMCG - Personal Care](https://www.sectoralpha.in/sectors/fmcg-personal-care), all 12 compared on one page. ## Which companies are close to Marico in size? Marico is the 2nd largest of 12 FMCG - Personal Care companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Hindustan Unilever. Just below it: Godrej Consumer Products, Dabur India, Colgate-Palmolive (India), Gillette India and Procter & Gamble Hygiene and Health Care. ### FMCG - Personal Care companies close in size

1. [Hindustan Unilever Ltd](https://www.sectoralpha.in/stocks/hindustan-unilever-ltd) ₹4,38,105 crore
2. Marico Ltd ₹1,04,016 crore
3. [Godrej Consumer Products Ltd](https://www.sectoralpha.in/stocks/godrej-consumer-products-ltd) ₹83,719 crore
4. [Dabur India Ltd](https://www.sectoralpha.in/stocks/dabur-india-ltd) ₹64,856 crore
5. [Colgate-Palmolive (India) Ltd](https://www.sectoralpha.in/stocks/colgate-palmolive-indialtd) ₹43,423 crore
6. [Gillette India Ltd](https://www.sectoralpha.in/stocks/gillette-india-ltd) ₹23,064 crore
7. [Procter & Gamble Hygiene and Health Care Ltd](https://www.sectoralpha.in/stocks/procter-gamble-hygiene-and-health-care-ltd) ₹22,239 crore

[All 12 FMCG - Personal Care companies, largest first](https://www.sectoralpha.in/sectors/fmcg-personal-care#all-companies)

### Companies close in size in other industries

1. [Canara Bank](https://www.sectoralpha.in/stocks/canara-bank) ₹1,06,616 crore · Banks - PSU
2. [One 97 Communications Ltd](https://www.sectoralpha.in/stocks/one-97-communications-ltd) ₹1,04,984 crore · E-Commerce - Platform - Utility
3. Marico Ltd ₹1,04,016 crore
4. [Lodha Developers Ltd](https://www.sectoralpha.in/stocks/lodha-developers-ltd) ₹1,03,642 crore · Realty - National
5. [Power Finance Corporation Ltd](https://www.sectoralpha.in/stocks/power-finance-corporation-ltd) ₹1,03,491 crore · Finance - PSU Lending

## What else do people ask about Marico? ### What is Marico's share price today? Marico Ltd's share price is ₹878.40, +22.0% over the past year. The whole company is worth ₹1,14,210 Cr on the market. It is at its highest price of the past 52 weeks (range ₹712 to ₹878), 10.3% above its 200-day average. The price has been rising for 80 weeks (as of 3 November 2026). ### What were Marico's latest quarterly results? Marico Ltd reported revenue of ₹3,957 Cr and net profit of ₹652 Cr for the Jun 2026 quarter. Revenue rose 22.9% and profit rose 27.1% compared with a year earlier. Earnings per share were ₹4.85. The operating margin was 21.0%, 1.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Marico's market cap? Marico Ltd's market capitalisation is ₹1,14,210 Cr at a share price of ₹878.40. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Marico performing? Marico Ltd's share price has been rising for 80 weeks. In its latest quarter, revenue rose 22.9% and profit rose 27.1% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 1 week running (as of 3 November 2026). ### Will Marico's share price go up? This page does not forecast Marico Ltd's share price. What it shows instead: the share price is ₹878.40, and it has been rising for 80 weeks. Its P/E of 60.5× is higher than 96% of its own last 11 years (as of 3 November 2026). ### Who owns Marico? Promoters own 58.8% of Marico Ltd, foreign institutions 22.3%, domestic institutions 14.1% and the public 4.5% (latest quarter). The biggest change over the last two years: Domestic institutions raised their stake by 3.0 percentage points over 8 quarters (as of 3 November 2026). ### Where is Marico in its business cycle? Marico Ltd's FY26 operating margin was 17.0%, against a 13-year range of 15.0% to 21.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 21.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Marico story? The main question: results are strong, and the P/E is higher than 96% of its own history. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Marico a stock worth studying right now? What the numbers show: Marico Ltd's results are improving, and its P/E is near the top of its own history, higher than 96% of past readings. The main open question: whether earnings grow enough to match the multiple. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Marico share price forecast for 2026? What management itself guided: FY27 consolidated revenue above ₹15,000 crore with double-digit growth. This is research, not advice. We’re not SEBI-registered.